14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CCCC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for C4 Therapeutics Inc
(Updated on Apr 25, 2024)

Sell candidate since Apr 08, 2024 Loss -18.54% PDF

The C4 Therapeutics Inc stock price fell by -3.55% on the last day (Thursday, 25th Apr 2024) from $6.47 to $6.24. During the last trading day the stock fluctuated 3.09% from a day low at $6.15 to a day high of $6.34. The price has fallen in 6 of the last 10 days and is down by -19.9% for this period. Volume has increased on the last day by 379 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $8.85 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.86 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 5.84% during the next 3 months and, with a 90% probability hold a price between $6.21 and $11.99 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CCCC Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The C4 Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.71 and $8.15. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 08, 2024, and so far it has fallen -43.27%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for C4 Therapeutics Inc stock

C4 Therapeutics Inc finds support from accumulated volume at $6.18 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.190 between high and low, or 3.09%. For the last week, the stock has had daily average volatility of 5.81%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CCCC) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect C4 Therapeutics Inc to open at $6.24, and during the day (based on 14 day Average True Range), to move between $5.75 and $6.73, which gives a possible trading interval of +/-$0.491 (+/-7.87%) up or down from last closing price. If C4 Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 15.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $6.18 (0.96%) than the resistance at $6.33 (1.44%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

C4 Therapeutics Inc will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.410. We will update the financials statements for C4 Therapeutics Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 14.73% in the first trading day after earnings release.

Is C4 Therapeutics Inc stock A Buy?

The C4 Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe C4 Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.426 Sell Candidate Unchanged

Predicted Opening Price for C4 Therapeutics Inc of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$6.24 ( 0.0534%) $6.24

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CCCC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 6.43 3.10 %
R2 6.36 1.94 %
R1 6.32 1.22 %
Current price: 6.24
Support S1 6.17 -1.11 %
S2 6.13 -1.83 %
S3 6.05 -2.99 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 7.72 23.72 %
R2 6.76 8.33 %
R1 6.33 1.44 %
Current price 6.24
Support S1 6.18 -0.96%
S2 6.01 -3.69%
S3 5.37 -13.94%

FAQ

What is the symbol for C4 Therapeutics Inc Stock and on which exchange is it traded?
The symbol for C4 Therapeutics Inc is CCCC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell C4 Therapeutics Inc Stock?
The C4 Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe C4 Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy C4 Therapeutics Inc Stock?
C4 Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy C4 Therapeutics Inc Stock.

What's the current price of C4 Therapeutics Inc Stock?
As of the end of day on the Apr 25, 2024, the price of an C4 Therapeutics Inc (CCCC) share was $6.24.

What is the 52-week high and low for C4 Therapeutics Inc Stock?
The 52-week high for C4 Therapeutics Inc Stock is $11.88 and the 52-week low is $1.06.

What is the market capitalization of C4 Therapeutics Inc Stock?
As of the Apr 25, 2024, the market capitalization of C4 Therapeutics Inc is 428.068M.

When is the next earnings date for C4 Therapeutics Inc?
The upcoming earnings date for C4 Therapeutics Inc is May 02, 2024.
Click to get the best stock tips daily for free!

About C4 Therapeutics Inc

C4 Therapeutics C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma an... CCCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT